Latest AI and machine learning research in leukemia for healthcare professionals.
Acute stroke alerts are often activated for non-cerebrovascular conditions, leading to false positiv...
Acute lymphoblastic leukemia is a highly heterogeneous hematologic malignancy that poses significant...
We overcome current limitations in Acute Myeloid Leukemia (AML) diagnosis by leveraging a transfer l...
Spinal cord injury (SCI) remains a devastating neurological condition with high global incidence and...
Congenital heart defects afflict nearly 1% of all births worldwide. While deep learning algorithms h...
Survivors of myocardial infarction (MI) are still at risk for adverse long-term outcomes such as all...
Repetitive transcranial magnetic stimulation (rTMS) targeting the primary motor cortex (M1) provides...
Although living donor kidney transplantation (LDKT) generally achieves excellent outcomes, 5–12% of ...
Up to 80% of women breast cancer survivors (BCS), particularly those treated with chemotherapy, repo...
Adult degenerative scoliosis arises after skeletal maturity in an initially normal spine, primarily ...
Glioblastoma is a highly malignant brain tumor in which maximal safe resection is associated with im...
Biological aging remains a central focus of research, from the scale of sub-cellular processes to wh...
Optimizing immunosuppressive therapy remains central to improving long-term outcomes after kidney tr...
Questionnaires that capture patient-reported symptomatology provide low-cost but potentially high-va...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, ...
Clinical machine learning (CML)for brain MRI often assumes that more data guarantees better performa...
The increasing availability of electronic health records (EHRs) provides opportunities to apply mach...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, u...
Cognitive motor dissociation (CMD) is associated with long-term recovery in acute brain injury, but ...
OBJECTIVE: This study aims to predict the early efficacy of induction chemotherapy (ICT) in patients...
BACKGROUND: Acute Myeloid Leukemia (AML) exhibits significant heterogeneity in clinical outcomes, ye...